BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3336 related articles for article (PubMed ID: 7562914)

  • 1. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
    Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
    J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of 2-beta-D-ribofuranosyloxazole-4-carboxamide (oxazofurin).
    Franchetti P; Cristalli G; Grifantini M; Cappellacci L; Vittori S; Nocentini G
    J Med Chem; 1990 Oct; 33(10):2849-52. PubMed ID: 2120442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL-60 cells.
    Kharbanda SM; Sherman ML; Kufe DW
    Blood; 1990 Feb; 75(3):583-8. PubMed ID: 1967538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.
    Jayaram HN; Gharehbaghi K; Jayaram NH; Rieser J; Krohn K; Paull KD
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1600-6. PubMed ID: 1354960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.
    Gebeyehu G; Marquez VE; Van Cott A; Cooney DA; Kelley JA; Jayaram HN; Ahluwalia GS; Dion RL; Wilson YA; Johns DG
    J Med Chem; 1985 Jan; 28(1):99-105. PubMed ID: 2856943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,2,4-Diazaphosphole nucleosides. Synthesis, structure, and antitumor activity of nucleosides with a lambda 3 phosphorus atom.
    Riley TA; Larson SB; Avery TL; Finch RA; Robins RK
    J Med Chem; 1990 Feb; 33(2):572-6. PubMed ID: 1967649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells.
    Zhen W; Jayaram HN; Marquez VE; Goldstein BM; Cooney DA; Weber G
    Biochem Biophys Res Commun; 1991 Oct; 180(2):933-8. PubMed ID: 1683233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydrogenase binding by tiazofurin anabolites.
    Goldstein BM; Bell JE; Marquez VE
    J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.
    Look KY; Sutton GP; Natsumeda Y; Eble JN; Stehman FB; Ehrlich CE; Olah E; Prajda N; Bosze P; Eckhardt S
    Gynecol Oncol; 1992 Oct; 47(1):66-70. PubMed ID: 1358769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
    Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 167.